What Happened?
Indianapolis, IN-based Outpost-Medicine Appointed Scott Byrd as President and Chief Executive Officer
About the Company
At Outpost, we are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company`s lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS). Located in Indianapolis and London, Outpost is a private company launched in 2016 with a $61 million Series A venture capital financing from Frazier Healthcare Partners, Adams Street Partners, Novo Holdings A/S, Vivo Capital, and Takeda Ventures.
About the Person
Scott Byrd is President and Chief Executive Officer at Outpost Medicine. Previously, Scott held various senior HR leadership roles in the industry.
Info Source
News
Short Profile